TNFRSF11B rs2073618: What Your Genotype Means
The rs2073618 variant is a common genetic polymorphism located in the TNFRSF11B gene, which produces a protein called osteoprotegerin (OPG) that is vital for bone health. Research moderately associates this variant with variations in bone mineral density and a potential susceptibility to diabetic retinopathy in individuals with type 2 diabetes.
What each genotype means
Common OPG genotype
This genotype is frequently observed in the general population. Research has investigated this variant's role in bone mineral density and diabetic retinopathy, though findings are often mixed and vary significantly by ancestry and clinical context.
This is a common genotype found across most global populations.
Common OPG genotype
Carriers of this genotype have one copy of each allele. Studies have explored potential associations between this variant and metabolic or bone-related traits, but results remain inconsistent across different ethnic groups and study designs.
This heterozygous genotype is widely distributed and common in many populations.
Common OPG genotype
This genotype represents the alternative homozygous state for this variant. While some studies suggest associations with specific health outcomes like diabetic retinopathy or bone density, these links are not definitive and may be influenced by other genetic or environmental factors.
This genotype is observed at a significant frequency in many populations, consistent with the variant's overall common status.
What is rs2073618 and the TNFRSF11B Gene?
The rs2073618 single nucleotide polymorphism (SNP) is located on chromosome 8 within the TNFRSF11B gene. This gene provides the body with instructions for producing a protein known as osteoprotegerin (OPG). OPG plays a critical role in bone remodeling, which is the continuous, lifelong process where mature bone tissue is removed from the skeleton and new bone tissue is formed. Specifically, OPG acts as a decoy receptor that binds to another protein called RANKL. By binding to RANKL, OPG prevents the excessive breakdown of bone by cells called osteoclasts. Because of its central role in maintaining bone homeostasis, variations in the TNFRSF11B gene, such as rs2073618, are frequently studied by geneticists to understand how slight changes in OPG production or function might influence skeletal health and other biological processes across different populations.
Associations with Bone Mineral Density
Because the TNFRSF11B gene is so heavily involved in bone health, researchers have extensively investigated whether the rs2073618 variant affects bone mineral density (BMD) and the risk of osteoporosis. The scientific evidence is currently moderate and somewhat mixed, often depending on the specific population being studied. Some genome-wide association studies (GWAS) and meta-analyses have found that the G allele of this variant is statistically associated with slightly lower lumbar spine bone mineral density and higher markers of bone turnover. Conversely, other studies, such as those observing postmenopausal women in specific Mexican or Chinese cohorts, have found no significant association between this specific SNP and bone density. This inconsistency highlights that while rs2073618 may play a role in skeletal health, its individual effect size is likely small, and bone density is ultimately a complex trait influenced by hundreds of genes alongside diet, exercise, and age.
Links to Diabetic Retinopathy
Beyond bone health, the rs2073618 variant has also been investigated for its potential connection to diabetic retinopathy, a complication of diabetes that affects the eyes. Osteoprotegerin is present in blood vessels, and researchers hypothesize it may influence vascular health. A notable study involving Slovenian patients with type 2 diabetes found that individuals carrying the CC genotype of rs2073618 had a statistically higher risk of developing diabetic retinopathy compared to those with the CG or GG genotypes. However, the evidence remains limited and ancestry-specific. For instance, a separate study focusing on a Chinese population found no significant association between the rs2073618 variant and diabetic retinopathy, though it did find links with a different SNP in the same gene. Therefore, while the statistical correlation in certain European cohorts is intriguing, the broader scientific consensus considers the evidence moderate, requiring more diverse, large-scale studies to fully understand the relationship.
How to Interpret Your Results
If a direct-to-consumer DNA test reveals your genotype for rs2073618, it is important to view this information through an educational lens rather than a diagnostic one. Having a genotype associated with lower bone mineral density or a higher risk of diabetic retinopathy does not mean you will inevitably develop osteoporosis or eye complications. Genetic variants like rs2073618 are just one small piece of a much larger puzzle. They represent statistical probabilities observed in large population studies, not personal medical diagnoses. You cannot use this single SNP to predict your future health outcomes or to make decisions about medications. If you have concerns about your bone density or diabetes management, the best course of action is to discuss these topics with a qualified healthcare provider. They can offer actionable advice on lifestyle factors, such as calcium intake, weight-bearing exercise, and blood sugar control, which have a far more substantial impact on your health than this single genetic variant.
How common is this variant?
The rs2073618 variant is very common globally, with the minor allele appearing in approximately 35% to 45% of people depending on their ancestry. It is widely distributed across European, Asian, and American populations, making it a frequently observed polymorphism in genetic studies.
Frequently asked questions
What is the TNFRSF11B gene?
The TNFRSF11B gene provides instructions for making osteoprotegerin (OPG), a protein essential for bone remodeling. It helps regulate the breakdown of bone tissue, ensuring your skeleton remains strong over time.
Can the rs2073618 variant cause osteoporosis?
No, this single genetic variant cannot cause osteoporosis on its own. While some studies link the G allele to slightly lower bone mineral density, bone health is a complex trait driven by many genes, diet, and lifestyle factors.
How does this variant relate to diabetes?
The rs2073618 variant does not cause diabetes, but some research suggests it may influence the risk of diabetic retinopathy, an eye complication. Specifically, the CC genotype has been associated with a higher risk of this condition in certain European populations with type 2 diabetes.
Should I change my diet or supplements based on my rs2073618 genotype?
You should not make medical or dietary changes based solely on this genetic variant. If you are concerned about your bone health, speak with a doctor or pharmacist about appropriate calcium and vitamin D supplementation.
Why do different studies show conflicting results for this SNP?
Genetic associations often vary depending on the specific ancestry, age, and sex of the population being studied. Because rs2073618 has a relatively small individual effect, its impact can be overshadowed by other genetic and environmental factors in different groups.
Sources & further reading
Educational information only, last refreshed 9/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2073618?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29